Brainstorm Cell Therapeutics | BCLI - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Biogen USD -243.8M 758.1M 2026-06
Brainstorm Cell Therapeutics USD -2.05M 198K 2026-03
Cipla INR 8.88B 2.74B 2026-06
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD -9.02M 65.06M 2026-03
CSL USD 2.64B 1.97B 2025-12
Cytokinetics USD -179.17M 2.05M 2026-06
Gilead Sciences USD 3.85B 1.17B 2026-06
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
Mesoblast USD -30.96M 11.14M 2025-12